These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
287 related articles for article (PubMed ID: 32308385)
1. Paclitaxel/IR1061-Co-Loaded Protein Nanoparticle for Tumor-Targeted and pH/NIR-II-Triggered Synergistic Photothermal-Chemotherapy. He L; Qing F; Li M; Lan D Int J Nanomedicine; 2020; 15():2337-2349. PubMed ID: 32308385 [TBL] [Abstract][Full Text] [Related]
2. Multifunctional Mesoporous Polydopamine With Hydrophobic Paclitaxel For Photoacoustic Imaging-Guided Chemo-Photothermal Synergistic Therapy. Zhang L; Yang P; Guo R; Sun J; Xie R; Yang W Int J Nanomedicine; 2019; 14():8647-8663. PubMed ID: 31806962 [TBL] [Abstract][Full Text] [Related]
3. Folate-receptor-targeted laser-activable poly(lactide- Liu F; Chen Y; Li Y; Guo Y; Cao Y; Li P; Wang Z; Gong Y; Ran H Int J Nanomedicine; 2018; 13():5139-5158. PubMed ID: 30233177 [TBL] [Abstract][Full Text] [Related]
4. A light-controllable specific drug delivery nanoplatform for targeted bimodal imaging-guided photothermal/chemo synergistic cancer therapy. Guo Y; Wang XY; Chen YL; Liu FQ; Tan MX; Ao M; Yu JH; Ran HT; Wang ZX Acta Biomater; 2018 Oct; 80():308-326. PubMed ID: 30240955 [TBL] [Abstract][Full Text] [Related]
5. "Navigate-dock-activate" anti-tumor strategy: Tumor micromilieu charge-switchable, hierarchically activated nanoplatform with ultrarapid tumor-tropic accumulation for trackable photothermal/chemotherapy. Cherukula K; Uthaman S; Park IK Theranostics; 2019; 9(9):2505-2525. PubMed ID: 31131050 [TBL] [Abstract][Full Text] [Related]
6. Co-delivery of paclitaxel (PTX) and docosahexaenoic acid (DHA) by targeting lipid nanoemulsions for cancer therapy. Li B; Tan T; Chu W; Zhang Y; Ye Y; Wang S; Qin Y; Tang J; Cao X Drug Deliv; 2022 Dec; 29(1):75-88. PubMed ID: 34964421 [TBL] [Abstract][Full Text] [Related]
7. Tumor-targeting and pH-sensitive lipoprotein-mimic nanocarrier for targeted intracellular delivery of paclitaxel. Chen C; Hu H; Qiao M; Zhao X; Wang Y; Chen K; Guo X; Chen D Int J Pharm; 2015 Mar; 480(1-2):116-27. PubMed ID: 25615984 [TBL] [Abstract][Full Text] [Related]
8. In vivo pharmacokinetics, biodistribution and anti-tumor effect of paclitaxel-loaded targeted chitosan-based polymeric micelle. Rezazadeh M; Emami J; Hasanzadeh F; Sadeghi H; Minaiyan M; Mostafavi A; Rostami M; Lavasanifar A Drug Deliv; 2016 Jun; 23(5):1707-17. PubMed ID: 25188785 [TBL] [Abstract][Full Text] [Related]
9. Co-delivery of cisplatin and paclitaxel by folic acid conjugated amphiphilic PEG-PLGA copolymer nanoparticles for the treatment of non-small lung cancer. He Z; Huang J; Xu Y; Zhang X; Teng Y; Huang C; Wu Y; Zhang X; Zhang H; Sun W Oncotarget; 2015 Dec; 6(39):42150-68. PubMed ID: 26517524 [TBL] [Abstract][Full Text] [Related]
10. Development and evaluation of novel tumor-targeting paclitaxel-loaded nano-carriers for ovarian cancer treatment: in vitro and in vivo. Yao S; Li L; Su XT; Wang K; Lu ZJ; Yuan CZ; Feng JB; Yan S; Kong BH; Song K J Exp Clin Cancer Res; 2018 Feb; 37(1):29. PubMed ID: 29478415 [TBL] [Abstract][Full Text] [Related]
11. Melanin-loaded biocompatible photosensitive nanoparticles for controlled drug release in combined photothermal-chemotherapy guided by photoacoustic/ultrasound dual-modality imaging. Wang W; Jing T; Xia X; Tang L; Huang Z; Liu F; Wang Z; Ran H; Li M; Xia J Biomater Sci; 2019 Oct; 7(10):4060-4074. PubMed ID: 31475710 [TBL] [Abstract][Full Text] [Related]
12. Development of biocompatible and VEGF-targeted paclitaxel nanodrugs on albumin and graphene oxide dual-carrier for photothermal-triggered drug delivery in vitro and in vivo. Deng W; Qiu J; Wang S; Yuan Z; Jia Y; Tan H; Lu J; Zheng R Int J Nanomedicine; 2018; 13():439-453. PubMed ID: 29403275 [TBL] [Abstract][Full Text] [Related]
13. MHI-148 Cyanine Dye Conjugated Chitosan Nanomicelle with NIR Light-Trigger Release Property as Cancer Targeting Theranostic Agent. Thomas RG; Moon MJ; Surendran SP; Park HJ; Park IK; Lee BI; Jeong YY Mol Imaging Biol; 2018 Aug; 20(4):533-543. PubMed ID: 29450802 [TBL] [Abstract][Full Text] [Related]
14. Folic Acid and Poly(ethylene glycol) Decorated Paclitaxel Nanocrystals Exhibit Enhanced Stability and Breast Cancer-Targeting Capability. Zhao J; Du J; Wang J; An N; Zhou K; Hu X; Dong Z; Liu Y ACS Appl Mater Interfaces; 2021 Mar; 13(12):14577-14586. PubMed ID: 33728919 [TBL] [Abstract][Full Text] [Related]
15. Dual Receptor-Targeted and Redox-Sensitive Polymeric Micelles Self-Assembled from a Folic Acid-Hyaluronic Acid-SS-Vitamin E Succinate Polymer for Precise Cancer Therapy. Yang Y; Li Y; Chen K; Zhang L; Qiao S; Tan G; Chen F; Pan W Int J Nanomedicine; 2020; 15():2885-2902. PubMed ID: 32425522 [TBL] [Abstract][Full Text] [Related]
16. Folic Acid-Modified Nanoerythrocyte for Codelivery of Paclitaxel and Tariquidar to Overcome Breast Cancer Multidrug Resistance. Zhong P; Chen X; Guo R; Chen X; Chen Z; Wei C; Li Y; Wang W; Zhou Y; Qin L Mol Pharm; 2020 Apr; 17(4):1114-1126. PubMed ID: 32176509 [TBL] [Abstract][Full Text] [Related]
17. Bioinspired tumor-homing nanoplatform for co-delivery of paclitaxel and siRNA-E7 to HPV-related cervical malignancies for synergistic therapy. Xu C; Liu W; Hu Y; Li W; Di W Theranostics; 2020; 10(7):3325-3339. PubMed ID: 32194871 [TBL] [Abstract][Full Text] [Related]
18. Folic acid modified lipid-bilayer coated mesoporous silica nanoparticles co-loading paclitaxel and tanshinone IIA for the treatment of acute promyelocytic leukemia. Li Z; Zhang Y; Zhu C; Guo T; Xia Q; Hou X; Liu W; Feng N Int J Pharm; 2020 Aug; 586():119576. PubMed ID: 32603839 [TBL] [Abstract][Full Text] [Related]
19. pH-Sensitive Biocompatible Nanoparticles of Paclitaxel-Conjugated Poly(styrene-co-maleic acid) for Anticancer Drug Delivery in Solid Tumors of Syngeneic Mice. Dalela M; Shrivastav TG; Kharbanda S; Singh H ACS Appl Mater Interfaces; 2015 Dec; 7(48):26530-48. PubMed ID: 26528585 [TBL] [Abstract][Full Text] [Related]
20. Optimization, Characterization and in vivo Evaluation of Paclitaxel-Loaded Folate-Conjugated Superparamagnetic Iron Oxide Nanoparticles. Gui G; Fan Z; Ning Y; Yuan C; Zhang B; Xu Q Int J Nanomedicine; 2021; 16():2283-2295. PubMed ID: 33776433 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]